The DOI matches its Crossref record; 139 of the 139 references it cites were found in a registry or an index.
A clinical perspective of IL‐1β as the gatekeeper of inflammation
Abstract
An expanding spectrum of acute and chronic non‐infectious inflammatory diseases is uniquely responsive to IL‐1β neutralization. IL‐1β‐mediated diseases are often called “auto‐inflammatory” and the dominant finding is the release of the active form of IL‐1β driven by endogenous molecules acting on the monocyte/macrophage. IL‐1β activity is tightly controlled and requires the conversion of the primary transcript, the inactive IL‐1β precursor, to the active cytokine by limited proteolysis. Limited proteolysis can take place extracellularly by serine proteases, released in particular by infiltrating neutrophils or intracellularly by the cysteine protease caspase‐1. Therefore, blocking IL‐1β resolves inflammation regardless of how the cytokine is released from the cell or how the precursor is cleaved. Endogenous stimulants such as oxidized fatty acids and lipoproteins, high glucose concentrations, uric acid crystals, activated complement, contents of necrotic cells, and cytokines, particularly IL‐1 itself, induce the synthesis of the inactive IL‐1β precursor, which awaits processing to the active form. Although bursts of IL‐1β precipitate acute attacks of systemic or local inflammation, IL‐1β also contributes to several chronic diseases. For example, ischemic injury, such as myocardial infarction or stroke, causes acute and extensive damage, and slowly progressive inflammatory processes take place in atherosclerosis, type 2 diabetes, osteoarthritis and smoldering myeloma. Evidence for the involvement of IL‐1β and the clinical results of reducing IL‐1β activity in this broad spectrum of inflammatory diseases are the focus of this review.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gout-associated uric acid crystals activate the NALP3 inflammasome
Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A., & Tschopp, J. (2006) · Nature · doi:10.1038/nature04516 · Cited by 5,326
Biologic basis for interleukin-1 in disease.
Dinarello, C. (1996) · Blood · doi:10.1182/blood.v87.6.2095.bloodjournal8762095 · Cited by 4,344
Self-citationThe NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance
Vandanmagsar, B., Youm, Y.-H., Ravussin, A., Galgani, J. E., Stadler, K., Mynatt, R. L., Ravussin, E., Stephens, J. M., & Dixit, V. D. (2011) · Nature Medicine · doi:10.1038/nm.2279 · Cited by 2,655
Interleukin-1-receptor antagonist in type 2 diabetes mellitus
Larsen, C. M., Faulenbach, M., Vaag, A., Vølund, A., Ehses, J. A., Seifert, B., Mandrup-Poulsen, T., & Donath, M. Y. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065213 · Cited by 1,798
Agostini, L., Martinon, F., Burns, K., McDermott, M. F., Hawkins, P. N., & Tschopp, J. (2004) · Immunity · doi:10.1016/s1074-7613(04)00046-9 · Cited by 1,768
Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1.
Dinarello, C. A., Cannon, J. G., Wolff, S. M., Bernheim, H. A., Beutler, B., Cerami, A., Figari, I. S., Palladino, M. A., & O'Connor, J. V. (1986) · The Journal of experimental medicine · doi:10.1084/jem.163.6.1433 · Cited by 1,472
Self-citationMcDermott, M. F., Aksentijevich, I., Galon, J., McDermott, E. M., Ogunkolade, B. W., Centola, M., Mansfield, E., Gadina, M., Karenko, L., Pettersson, T., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80721-7 · Cited by 1,408
Masters, S. L., Dunne, A., Subramanian, S. L., Hull, R. L., Tannahill, G. M., Sharp, F. A., Becker, C., Franchi, L., Yoshihara, E., Chen, Z., et al. (2010) · Nature Immunology · doi:10.1038/ni.1935 · Cited by 1,330
Interleukin-1 and the Pathogenesis of the Acute-Phase Response
Epstein, F. H., & Dinarello, C. A. (1984) · New England Journal of Medicine · doi:10.1056/nejm198411293112205 · Cited by 1,146
Self-citationGlucose-induced β cell production of IL-1β contributes to glucotoxicity in human pancreatic islets
Maedler, K., Sergeev, P., Ris, F., Oberholzer, J., Joller-Jemelka, H. I., Spinas, G. A., Kaiser, N., Halban, P. A., & Donath, M. Y. (2017) · Journal of Clinical Investigation · doi:10.1172/jci92172 · Cited by 1,114
Horror Autoinflammaticus: The Molecular Pathophysiology of Autoinflammatory Disease
Masters, S. L., Simon, A., Aksentijevich, I., & Kastner, D. L. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141627 · Cited by 1,065
Nucleotide sequence of human monocyte interleukin 1 precursor cDNA.
Auron, P. E., Webb, A. C., Rosenwasser, L. J., Mucci, S. F., Rich, A., Wolff, S. M., & Dinarello, C. A. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.24.7907 · Cited by 1,042
Self-citationThe role of cytokines in osteoarthritis pathophysiology
Fernandes, J. C., Martel‐Pelletier, J., & Pelletier, J. (2002) · Biorheology: The Official Journal of the International Society of Biorheology · doi:10.1177/0006355x2002039001002025 · Cited by 1,015
Glucose-induced β cell production of IL-1β contributes to glucotoxicity in human pancreatic islets
Maedler, K., Sergeev, P., Ris, F., Oberholzer, J., Joller-Jemelka, H. I., Spinas, G. A., Kaiser, N., Halban, P. A., & Donath, M. Y. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200215318 · Cited by 1,005
An Autoinflammatory Disease with Deficiency of the Interleukin-1–Receptor Antagonist
Aksentijevich, I., Masters, S. L., Ferguson, P. J., Dancey, P., Frenkel, J., van Royen-Kerkhoff, A., Laxer, R., Tedgård, U., Cowen, E. W., Pham, T.-H., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0807865 · Cited by 987
Interleukin-1 Type II Receptor: A Decoy Target for IL-1 That Is Regulated by IL-4
Colotta, F., Re, F., Muzio, M., Bertini, R., Polentarutti, N., Sironi, M., Giri, J. G., Dower, S. K., Sims, J. E., & Mantovani, A. (1993) · Science · doi:10.1126/science.8332913 · Cited by 980
Type I Interferon Inhibits Interleukin-1 Production and Inflammasome Activation
Guarda, G., Braun, M., Staehli, F., Tardivel, A., Mattmann, C., Förster, I., Farlik, M., Decker, T., Du Pasquier, R. A., Romero, P., et al. (2011) · Immunity · doi:10.1016/j.immuni.2011.02.006 · Cited by 933
Neonatal-Onset Multisystem Inflammatory Disease Responsive to Interleukin-1β Inhibition
Goldbach-Mansky, R., Dailey, N. J., Canna, S. W., Gelabert, A., Jones, J., Rubin, B. I., Kim, H. J., Brewer, C., Zalewski, C., Wiggs, E., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055137 · Cited by 930
Pascual, V., Allantaz, F., Arce, E., Punaro, M., & Banchereau, J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050473 · Cited by 922
Clinical Course and Prognosis of Smoldering (Asymptomatic) Multiple Myeloma
Kyle, R. A., Remstein, E. D., Therneau, T. M., Dispenzieri, A., Kurtin, P. J., Hodnefield, J. M., Larson, D. R., Plevak, M. F., Jelinek, D. F., Fonseca, R., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa070389 · Cited by 921
Chen, C.-J., Kono, H., Golenbock, D., Reed, G., Akira, S., & Rock, K. L. (2007) · Nature Medicine · doi:10.1038/nm1603 · Cited by 876
Use of Canakinumab in the Cryopyrin-Associated Periodic Syndrome
Lachmann, H. J., Kone-Paut, I., Kuemmerle-Deschner, J. B., Leslie, K. S., Hachulla, E., Quartier, P., Gitton, X., Widmer, A., Patel, N., & Hawkins, P. N. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810787 · Cited by 869
Cloning and expression of murine interleukin-1 cDNA in Escherichia coli
Lomedico, P. T., Gubler, U., Hellmann, C. P., Dukovich, M., Giri, J. G., Pan, Y.-C. E., Collier, K., Semionow, R., Chua, A. O., & Mizel, S. B. (1984) · Nature · doi:10.1038/312458a0 · Cited by 816
Netea, M. G., Nold-Petry, C. A., Nold, M. F., Joosten, L. A. B., Opitz, B., van der Meer, J. H. M., van de Veerdonk, F. L., Ferwerda, G., Heinhuis, B., Devesa, I., et al. (2009) · Blood · doi:10.1182/blood-2008-03-146720 · Cited by 792
Self-citationInterleukin-18 Binding Protein
Novick, D., Kim, S.-H., Fantuzzi, G., Reznikov, L. L., Dinarello, C. A., & Rubinstein, M. (1999) · Immunity · doi:10.1016/s1074-7613(00)80013-8 · Cited by 779
Self-citationHorai, R., Saijo, S., Tanioka, H., Nakae, S., Sudo, K., Okahara, A., Ikuse, T., Asano, M., & Iwakura, Y. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.2.313 · Cited by 749
A pilot study of IL-1 inhibition by anakinra in acute gout
So, A., De Smedt, T., Revaz, S., & Tschopp, J. (2007) · Arthritis Research & Therapy · doi:10.1186/ar2143 · Cited by 727
Stienstra, R., Joosten, L. A. B., Koenen, T., van Tits, B., van Diepen, J. A., van den Berg, S. A. A., Rensen, P. C. N., Voshol, P. J., Fantuzzi, G., Hijmans, A., et al. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.11.011 · Cited by 676
Interleukin-1–Receptor Antagonist in the Muckle–Wells Syndrome
Hawkins, P. N., Lachmann, H. J., & McDermott, M. F. (2003) · New England Journal of Medicine · doi:10.1056/nejm200306193482523 · Cited by 654
Hoffman, H. M., Throne, M. L., Amar, N. J., Sebai, M., Kivitz, A. J., Kavanaugh, A., Weinstein, S. P., Belomestnov, P., Yancopoulos, G. D., Stahl, N., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23687 · Cited by 577
Quartier, P., Allantaz, F., Cimaz, R., Pillet, P., Messiaen, C., Bardin, C., Bossuyt, X., Boutten, A., Bienvenu, J., Duquesne, A., et al. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.134254 · Cited by 558
Hoffman, H. M., Rosengren, S., Boyle, D. L., Cho, J. Y., Nayar, J., Mueller, J. L., Anderson, J. P., Wanderer, A. A., & Firestein, G. S. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17401-1 · Cited by 552
Dinarello, C. A., Ikejima, T., Warner, S. J. C., Orencole, S. F., Lonnemann, G., Cannon, J. G., & Libby, P. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.6.1902 · Cited by 537
Self-citationChevalier, X., Goupille, P., Beaulieu, A. D., Burch, F. X., Bensen, W. G., Conrozier, T., Loeuille, D., Kivitz, A. J., Silver, D., & Appleton, B. E. (2009) · Arthritis Care & Research · doi:10.1002/art.24096 · Cited by 533
Cytotoxicity of Human p I 7 Interleukin-1 for Pancreatic Islets of Langerhans
Bendtzen, K., Mandrup-Poulsen, T., Nerup, J., Nielsen, J. H., Dinarello, C. A., & Svenson, M. (1986) · Science · doi:10.1126/science.3086977 · Cited by 529
Self-citationChen, C.-J. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28075 · Cited by 476
Nigrovic, P. A., Mannion, M., Prince, F. H. M., Zeft, A., Rabinovich, C. E., van Rossum, M. A. J., Cortis, E., Pardeo, M., Miettunen, P. M., Janow, G., et al. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30128 · Cited by 463
Isolation of an interleukin‐1‐like factor from human joint effusions
Wood, D. D., Ihrie, E. J., Dinarello, C. A., & Cohen, P. L. (1983) · Arthritis & Rheumatism · doi:10.1002/art.1780260806 · Cited by 445
Self-citationJoosten, L. A. B., Helsen, M. M., Saxne, T., van de Loo, F. A. J., Heinegård, D. K., & van den Berg, W. B. (1999) · PubMed · Cited by 441
Improvement in Castleman's disease by humanized anti-interleukin-6 receptor antibody therapy
Nishimoto, N., Sasai, M., Shima, Y., Nakagawa, M., Matsumoto, T., Shirai, T., Kishimoto, T., & Yoshizaki, K. (2000) · Blood · doi:10.1182/blood.v95.1.56 · Cited by 441
Abbate, A., Kontos, M. C., Grizzard, J. D., Biondi-Zoccai, G. G. L., Van Tassell, B. W., Robati, R., Roach, L. M., Arena, R. A., Roberts, C. S., Varma, A., et al. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.12.059 · Cited by 415
Self-citationAn Autoinflammatory Disease Due to Homozygous Deletion of the IL1RN Locus
Reddy, S., Jia, S., Geoffrey, R., Lorier, R., Suchi, M., Broeckel, U., Hessner, M. J., & Verbsky, J. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0809568 · Cited by 411
Lequerré, T., Quartier, P., Rosellini, D., Alaoui, F., De Bandt, M., Mejjad, O., Kone-Paut, I., Michel, M., Dernis, E., Khellaf, M., et al. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.076034 · Cited by 406
Joosten, L. A. B., Helsen, M. M. A., Saxne, T., van de Loo, F. A. J., Heinegård, D., & van den Berg, W. B. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.9.5049 · Cited by 405
Sustained effects of interleukin-1 receptor antagonist treatment in type 2 diabetes
Larsen, C. M., Faulenbach, M., Vaag, A., Ehses, J. A., Donath, M. Y., & Mandrup-Poulsen, T. (2009) · Diabetes Care · doi:10.2337/dc09-0533 · Cited by 401
Update on gout: new therapeutic strategies and options
Terkeltaub, R. (2010) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2009.236 · Cited by 387
Gattorno, M., Piccini, A., Lasigliè, D., Tassi, S., Brisca, G., Carta, S., Delfino, L., Ferlito, F., Pelagatti, M. A., Caroli, F., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23437 · Cited by 382
Abbate, A., Salloum, F. N., Vecile, E., Das, A., Hoke, N. N., Straino, S., Biondi-Zoccai, G. G. L., Houser, J.-E., Qureshi, I. Z., Ownby, E. D., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.740233 · Cited by 360
Blockade of TNF-α rapidly inhibits pain responses in the central nervous system
Hess, A., Axmann, R., Rech, J., Finzel, S., Heindl, C., Kreitz, S., Sergeeva, M., Saake, M., Garcia, M., Kollias, G., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011774108 · Cited by 356
Rapid responses to anakinra in patients with refractory adult‐onset Still's disease
Fitzgerald, A. A., LeClercq, S. A., Yan, A., Homik, J. E., & Dinarello, C. A. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21061 · Cited by 350
Self-citationA urine inhibitor of interleukin 1 activity that blocks ligand binding.
Seckinger, P., Lowenthal, J. W., Williamson, K., Dayer, J. M., & MacDonald, H. R. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.5.1546 · Cited by 345
Anakinra for Rheumatoid Arthritis: A Systematic Review
MERTENS, M., & SINGH, J. A. (2009) · The Journal of Rheumatology · doi:10.3899/jrheum.090074 · Cited by 344
Islet Inflammation Impairs the Pancreatic β-Cell in Type 2 Diabetes
Donath, M. Y., Böni-Schnetzler, M., Ellingsgaard, H., & Ehses, J. A. (2009) · Physiology · doi:10.1152/physiol.00032.2009 · Cited by 330
Cohen, I., Rider, P., Carmi, Y., Braiman, A., Dotan, S., White, M. R., Voronov, E., Martin, M. U., Dinarello, C. A., & Apte, R. N. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0915018107 · Cited by 329
Self-citationJoosten, L. A. B., Netea, M. G., Mylona, E., Koenders, M. I., Malireddi, R. K. S., Oosting, M., Stienstra, R., van de Veerdonk, F. L., Stalenhoef, A. F., Giamarellos‐Bourboulis, E. J., et al. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27667 · Cited by 328
Increased secretion and expression of myostatin in skeletal muscle from extremely obese women
Hittel, D. S., Berggren, J. R., Shearer, J., Boyle, K., & Houmard, J. A. (2009) · Diabetes · doi:10.2337/db08-0943 · Cited by 324
Hoffman, H. M., Wanderer, A. A., & Broide, D. H. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.118790 · Cited by 324
Affinity-purified human Interleukin I is cytotoxic to isolated islets of Langerhans
Mandrup-Poulsen, T., Bendtzen, K., Nerup, J., Dinarello, C. A., Svenson, M., & Nielsen, J. H. (1986) · Diabetologia · doi:10.1007/bf02427283 · Cited by 324
Self-citationArend, W. P., Joslin, F. G., & Massoni, R. J. (1985) · The Journal of Immunology · doi:10.4049/jimmunol.134.6.3868 · Cited by 322
The German etanercept registry for treatment of juvenile idiopathic arthritis
Horneff, G., Schmeling, H., Biedermann, T., Foeldvari, I., Ganser, G., Girschick, H. J., Hospach, T., Huppertz, H. I., Keitzer, R., Küster, R. M., et al. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.014886 · Cited by 318
Arterial Inflammation in Mice Lacking the Interleukin 1 Receptor Antagonist Gene
Nicklin, M. J. H., Hughes, D. E., Barton, J. L., Ure, J. M., & Duff, G. W. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.2.303 · Cited by 317
So, A., De Meulemeester, M., Pikhlak, A., Yücel, A. E., Richard, D., Murphy, V., Arulmani, U., Sallstig, P., & Schlesinger, N. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27600 · Cited by 315
Gattorno, M., Pelagatti, M. A., Meini, A., Obici, L., Barcellona, R., Federici, S., Buoncompagni, A., Plebani, A., Merlini, G., & Martini, A. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23475 · Cited by 312
Terkeltaub, R., Sundy, J. S., Schumacher, H. R., Murphy, F., Bookbinder, S., Biedermann, S., Wu, R., Mellis, S., & Radin, A. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.108936 · Cited by 300
Joosten, L. A. B., Netea, M. G., Fantuzzi, G., Koenders, M. I., Helsen, M. M. A., Sparrer, H., Pham, C. T., van der Meer, J. W. M., Dinarello, C. A., & van den Berg, W. B. (2009) · Arthritis & Rheumatism · doi:10.1002/art.25006 · Cited by 296
Self-citationStojanov, S., Lapidus, S., Chitkara, P., Feder, H., Salazar, J. C., Fleisher, T. A., Brown, M. R., Edwards, K. M., Ward, M. M., Colbert, R. A., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1103681108 · Cited by 294
Okamoto, M., Liu, W., Luo, Y., Tanaka, A., Cai, X., Norris, D. A., Dinarello, C. A., & Fujita, M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.064907 · Cited by 293
Self-citationMitochondria: Sovereign of inflammation?
Tschopp, J. (2011) · European Journal of Immunology · doi:10.1002/eji.201141436 · Cited by 292
Severe imbalance of IL-18/IL-18BP in patients with secondary hemophagocytic syndrome
Mazodier, K. (2005) · Blood · doi:10.1182/blood-2005-05-1980 · Cited by 290
Pyrin Activates the ASC Pyroptosome in Response to Engagement by Autoinflammatory PSTPIP1 Mutants
Yu, J.-W., Fernandes-Alnemri, T., Datta, P., Wu, J., Juliana, C., Solorzano, L., McCormick, M., Zhang, Z., & Alnemri, E. S. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.08.029 · Cited by 287
Human leukocytic pyrogen: purification and development of a radioimmunoassay.
Dinarello, C. A., Renfer, L., & Wolff, S. M. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.10.4624 · Cited by 272
Self-citationIL‐1: Discoveries, controversies and future directions
Dinarello, C. A. (2010) · European Journal of Immunology · doi:10.1002/eji.201040319 · Cited by 268
Self-citationNeven, B., Marvillet, I., Terrada, C., Ferster, A., Boddaert, N., Couloignier, V., Pinto, G., Pagnier, A., Bodemer, C., Bodaghi, B., et al. (2010) · Arthritis & Rheumatism · doi:10.1002/art.25057 · Cited by 265
ATP Acts as an Agonist to Promote Stimulus-Induced Secretion of IL-1β and IL-18 in Human Blood
Perregaux, D. G., McNiff, P., Laliberte, R., Conklyn, M., & Gabel, C. A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.8.4615 · Cited by 255
Gattorno, M., Tassi, S., Carta, S., Delfino, L., Ferlito, F., Pelagatti, M. A., D'Osualdo, A., Buoncompagni, A., Alpigiani, M. G., Alessio, M., et al. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22842 · Cited by 247
Lust, J. A., Lacy, M. Q., Zeldenrust, S. R., Dispenzieri, A., Gertz, M. A., Witzig, T. E., Kumar, S., Hayman, S. R., Russell, S. J., Buadi, F. K., et al. (2009) · Mayo Clinic Proceedings · doi:10.4065/84.2.114 · Cited by 246
Schindler, R., Gelfand, J., & Dinarello, C. (1990) · Blood · doi:10.1182/blood.v76.8.1631.1631 · Cited by 228
Self-citationSchindler, R., Clark, B. D., & Dinarello, C. A. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)86936-8 · Cited by 227
Self-citationBrenner, M., Ruzicka, T., Plewig, G., Thomas, P., & Herzer, P. (2009) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2009.09404.x · Cited by 225
Cytokines and β-Cell Biology: from Concept to Clinical Translation
Donath, M. Y., Størling, J., Berchtold, L. A., Billestrup, N., & Mandrup-Poulsen, T. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0033 · Cited by 222
Blocking the effects of IL-1 in rheumatoid arthritis protects bone and cartilage.
Abramson, S. B. (2002) · Rheumatology · doi:10.1093/rheumatology/41.9.972 · Cited by 217
Interleukin-1 induces interleukin-8 secretion from endothelial cells by a juxtacrine mechanism
Kaplanski, G., Farnarier, C., Kaplanski, S., Porat, R., Shapiro, L., Bongrand, P., & Dinarello, C. (1994) · Blood · doi:10.1182/blood.v84.12.4242.bloodjournal84124242 · Cited by 209
Self-citationMeinzer, U., Quartier, P., Alexandra, J.-F., Hentgen, V., Retornaz, F., & Koné-Paut, I. (2011) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2010.11.003 · Cited by 205
Anakinra for flares of pyogenic arthritis in PAPA syndrome
Dierselhuis, M. P. (2005) · Rheumatology · doi:10.1093/rheumatology/keh479 · Cited by 200
Rosenwasser, L. J., Dinarello, C. A., & Rosenthal, A. S. (1979) · The Journal of experimental medicine · doi:10.1084/jem.150.3.709 · Cited by 183
Self-citationKuemmerle-Deschner, J. B., Tyrrell, P. N., Koetter, I., Wittkowski, H., Bialkowski, A., Tzaribachev, N., Lohse, P., Koitchev, A., Deuter, C., Foell, D., et al. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30149 · Cited by 177
Lipsker, D. (2010) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-5-38 · Cited by 177
On-demand anakinra treatment is effective in mevalonate kinase deficiency
Bodar, E. J., Kuijk, L. M., Drenth, J. P. H., van der Meer, J. W. M., Simon, A., & Frenkel, J. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2011.149922 · Cited by 168
Picco, P. P., Brisca, G., Traverso, F., Loy, A., Gattorno, M., & Martini, A. (2008) · Arthritis & Rheumatism · doi:10.1002/art.24174 · Cited by 167
Bodar, E. J., van der Hilst, J. C. H., Drenth, J. P. H., van der Meer, J. W. M., & Simon, A. (2005) · PubMed · Cited by 166
Beneficial response to interleukin 1 receptor antagonist in traps
Simon, A., Bodar, E. J., van der Hilst, J. C. H., van der Meer, J. W. M., Fiselier, T. J. W., Cuppen, M. P. J. M., & Drenth, J. P. H. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2004.02.039 · Cited by 164
A case of macrophage activation syndrome successfully treated with anakinra
Kelly, A., & Ramanan, A. V. (2008) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0919 · Cited by 147
Management of treatment resistant inflammation of acute on chronic tophaceous gout with anakinra
McGonagle, D. G., Tan, A. L., Shankaranarayana, S., Madden, J. M., Emery, P., & McDermott, M. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.073759 · Cited by 146
Rationale and efficacy of interleukin-1 targeting in Erdheim–Chester disease
Aouba, A., Georgin‐Lavialle, S., Pagnoux, C., Silva, N. M., Renand, A., Galateau-Sallé, F., Toquin, S. L., Bensadoun, H., Larousserie, F., Silvera, S., et al. (2010) · Blood · doi:10.1182/blood-2010-04-279240 · Cited by 144
Brück, N., Suttorp, M., Kabus, M., Heubner, G., Gahr, M. L., & Peßler, F. (2011) · JCR Journal of Clinical Rheumatology · doi:10.1097/rhu.0b013e318205092d · Cited by 142
Giamarellos‐Bourboulis, E. J., Mouktaroudi, M., Bodar, E. J., van der Ven, J., Kullberg, B.-J., Netea, M. G., & van der Meer, J. W. M. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.082222 · Cited by 139
The Effects of Treatment with Interleukin-1α on Platelet Recovery after High-Dose Carboplatin
Smith, J. W., Longo, D. L., Alvord, W. G., Janik, J. E., Sharfman, W. H., Gause, B. L., Curti, B. D., Creekmore, S. P., Holmlund, J., Fenton, R. G., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199303183281103 · Cited by 138
Beneficial response to anakinra and thalidomide in Schnitzler's syndrome
de Koning, H. D., Bodar, E. J., Simon, A., van der Hilst, J. C. H., Netea, M. G., & van der Meer, J. W. M. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.045245 · Cited by 138
Disease-associated amyloid and misfolded protein aggregates activate the inflammasome
Masters, S. L., & O'Neill, L. A. J. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.01.005 · Cited by 135
Dinarello, C. A., Rosenwasser, L. J., & Wolff, S. (1981) · The Journal of Immunology · doi:10.4049/jimmunol.127.6.2517 · Cited by 132
Self-citationResistant Behçet Disease Responsive to Anakinra
Botsios, C., Sfriso, P., Furlan, A., Punzi, L., & Dinarello, C. A. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-4-200808190-00018 · Cited by 131
Self-citationSchindler, R., Ghezzi, P., & Dinarello, C. A. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.6.2216 · Cited by 128
Self-citationNedjai, B., Hitman, G. A., Quillinan, N., Coughlan, R. J., Church, L. D., McDermott, M., & Turner, M. D. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24294 · Cited by 117
Lepore, L., Paloni, G., Caorsi, R., Alessio, M., Rigante, D., Ruperto, N., Cattalini, M., Tommasini, A., Zulian, F., Ventura, A., et al. (2010) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2010.02.040 · Cited by 114
Abbate, A., Tassell, B. W. V., Seropian, I. M., Toldo, S. A., Robati, R., Varma, A., Salloum, F. N., Smithson, L. A., & Dinarello, C. A. (2010) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfq017 · Cited by 113
Self-citationCailliez, M., Garaix, F., Rousset‐Rouvière, C., Bruno, D., Koné‐Paut, I., Sarles, J., Chabrol, B., & Tsimaratos, M. (2006) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-006-0408-7 · Cited by 112
Vaitla, P., Radford, P. M., Tighe, P. J., Powell, R. J., McDermott, E. M., Todd, I., & Drewe, E. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30215 · Cited by 103
Colina, M., Pizzirani, C., Khodeir, M., Falzoni, S., Bruschi, M., Trotta, F., & Virgilio, F. D. (2010) · Rheumatology · doi:10.1093/rheumatology/keq074 · Cited by 89
Interleukin-18 Promotes Joint Inflammation and Induces Interleukin-1-Driven Cartilage Destruction
Joosten, L. A. B., Smeets, R. L., Koenders, M. I., van den Bersselaar, L. A. M., Helsen, M. M. A., Oppers‐Walgreen, B., Lubberts, E., Iwakura, Y., van de Loo, F. A. J., & van den Berg, W. B. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63357-3 · Cited by 86
THE ROLE OF INTERLEUKIN-1β IN THE PATHOGENESIS OF MULTIPLE MYELOMA
Lust, J. A., & Donovan, K. A. (1999) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(05)70115-5 · Cited by 85
Neurologic manifestations of the cryopyrin-associated periodic syndrome
Kitley, J., Lachmann, H. J., Pinto, A. A., & Ginsberg, L. (2010) · Neurology · doi:10.1212/wnl.0b013e3181d9ed69 · Cited by 83
Kaspar, R. L., & Gehrke, L. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.1.277 · Cited by 77
Boettger, M. K., Weber, K., Grossmann, D., Gajda, M. R., Bauer, R., Bär, K., Schulz, S., Voss, A., Geis, C., Bräuer, R., et al. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27380 · Cited by 76
Schnitzler syndrome: Treatment failure to rituximab but response to anakinra
Eiling, E., Möller, M., Kreiselmaier, I., Brasch, J., & Schwarz, T. (2007) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2007.03.036 · Cited by 75
Behrens, E. M., Kreiger, P. A., Cherian, S., & Cron, R. Q. (2006) · PubMed · Cited by 75
Successful Treatment of Castleman's Disease with Interleukin-1 Receptor Antagonist (Anakinra)
El-Osta, H. E., Jankú, F., & Kurzrock, R. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0156 · Cited by 74
Anakinra suppresses familial Mediterranean fever crises in a colchicine-resistant patient.
Mitroulis, I., Papadopoulos, V. P., Konstantinidis, T. G., & Ritis, K. (2008) · PubMed · Cited by 66
Kolivras, A., Theunis, A., Ferster, A., Lipsker, D. M., Saß, U., Dussart, A., & André, J. (2010) · Journal of Cutaneous Pathology · doi:10.1111/j.1600-0560.2010.01638.x · Cited by 64
Jung, N., Hellmann, M., Hoheisel, R., Lehmann, C., Haase, I., Perniok, A., Hallek, M. J., & RUBBERT, A. (2010) · Clinical Rheumatology · doi:10.1007/s10067-010-1504-5 · Cited by 62
Case of anakinra as a steroid‐sparing agent for gout inflammation
Gratton, S. B., Scalapino, K. J., & Fye, K. H. (2009) · Arthritis Care & Research · doi:10.1002/art.24694 · Cited by 60
Monocytes from familial cold autoinflammatory syndrome patients are activated by mild hypothermia
Rosengren, S., Mueller, J. L., Anderson, J. P., Niehaus, B. L., Misaghi, A., Anderson, S., Boyle, D. L., & Hoffman, H. M. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.12.649 · Cited by 58
Anakinra treatment for systemic onset juvenile idiopathic arthritis (SOJIA)
Ohlsson, V., Baildam, E. M., Foster, H., Jandial, S., Pain, C. E., Strike, H., & Ramanan, A. V. (2007) · Lara D. Veeken · doi:10.1093/rheumatology/ken030 · Cited by 55
Cantarini, L., Lucherini, O. M., Cimaz, R., & Galeazzi, M. (2010) · PubMed · Cited by 55
Cytophagic histiocytic panniculitis and hemophagocytic lymphohistiocytosis: an overview
Aronson, I. K., & Worobec, S. M. (2010) · Dermatologic Therapy · doi:10.1111/j.1529-8019.2010.01339.x · Cited by 54
Furlan, A., Botsios, C., Ruffatti, A., TODESCO, S., & Punzi, L. (2008) · Joint Bone Spine · doi:10.1016/j.jbspin.2007.07.010 · Cited by 53
Bodar, E. J., Simon, A., de Visser, M., & van der Meer, J. W. M. (2009) · PubMed · Cited by 51
Torcia, M. G., Lucibello, M., Vannier, E. G., et al. (1996) · PubMed · Cited by 48
Raffeiner, B., Botsios, C., Dinarello, C. A., Ometto, F., Punzi, L., & Ramonda, R. (2010) · Joint Bone Spine · doi:10.1016/j.jbspin.2010.09.014 · Cited by 45
Self-citationDuff, G. W., Atkins, E., & Malawista, S. E. (1983) · PubMed · Cited by 43
IL-1 Inhibition With Anakinra in a Patient With Refractory Gout
Singh, D., & Huston, K. K. (2009) · JCR Journal of Clinical Rheumatology · doi:10.1097/rhu.0b013e3181be2423 · Cited by 39
Tilg, H., Trehu, E., Shapiro, L., Pape, D., Atkins, M. B., Dinarello, C. A., & Mier, J. W. (1994) · Cytokine · doi:10.1016/1043-4666(94)90044-2 · Cited by 38
Self-citationBotsios, C., Sfriso, P., Punzi, L., & TODESCO, S. (2007) · Scandinavian Journal of Rheumatology · doi:10.1080/03009740600938647 · Cited by 37
Hennig, S., Bayegan, K., Uffmann, M., Thalhammer, F., & Winkler, S. (2010) · Rheumatology International · doi:10.1007/s00296-010-1429-y · Cited by 33
Clinical Benefits of Intra-Articular Anakinra for Arthrofibrosis
Brown, C. A., Toth, A. P., & Magnussen, B. (2010) · Orthopedics · doi:10.3928/01477447-20101021-09 · Cited by 31
Endocrine Effects of IL-1α and β Administered in a Phase I Trial to Patients with Advanced Cancer
Curti, B. D., Urba, W. J., Longo, D. L., Janik, J. E., Sharfman, W. H., Miller, L. L., Cizza, G., Shimizu, M., Oppenheim, J. J., Alvord, W. G., et al. (1996) · Journal of Immunotherapy · doi:10.1097/00002371-199603000-00007 · Cited by 23
Chauffier, K., London, J., Beaudouin, C., & Fautrel, B. (2009) · La Presse Médicale · doi:10.1016/j.lpm.2009.01.012 · Cited by 23
Induction of interleukin 1 receptor antagonist after interleukin 1 therapy in patients with cancer.
Kopp, W. C., Urba, W. J., Rager, H., Alvord, W. G., Oppenheim, J. J., Smith, J. W., & Longo, D. L. (1996) · PubMed · Cited by 20
Mirkinson, L. J., Nagle, D., Jones, O. Y., & Kadom, N. (2006) · JCR Journal of Clinical Rheumatology · doi:10.1097/01.rhu.0000208650.99508.4e · Cited by 19
Genant, H. K., Bresnihan, B., Ng, E., et al. (2001) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2001.1196 · Cited by 18
Cited by
Inflammasome activation and regulation: toward a better understanding of complex mechanisms
Zheng, D., Liwinski, T., & Elinav, E. (2020) · Cell Discovery · doi:10.1038/s41421-020-0167-x · Cited by 1,026
Human Monocytes Engage an Alternative Inflammasome Pathway
Gaidt, M. M., Ebert, T. S., Chauhan, D., Schmidt, T., Schmid-Burgk, J. L., Rapino, F., Robertson, A. A. B., Cooper, M. A., Graf, T., & Hornung, V. (2016) · Immunity · doi:10.1016/j.immuni.2016.01.012 · Cited by 785
Abderrazak, A., Syrovets, T., Couchie, D., El Hadri, K., Friguet, B., Simmet, T., & Rouis, M. (2015) · Redox Biology · doi:10.1016/j.redox.2015.01.008 · Cited by 732
Neutrophil cell surface receptors and their intracellular signal transduction pathways
Futosi, K., Fodor, S., & Mócsai, A. (2013) · International Immunopharmacology · doi:10.1016/j.intimp.2013.06.034 · Cited by 642
The role of IL-1β and TNF-α in intervertebral disc degeneration
Wang, Y., Che, M., Xin, J., Zheng, Z., Li, J., & Zhang, S. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110660 · Cited by 627
Metadata
- Authors
- Dinarello, C. A.
- Venue
- European Journal of Immunology
- Publisher
- Wiley
- Published
- 2011-04-26
- Volume
- 41
- Issue
- 5
- Pages
- 1203-1217
- ISSN
- 0014-2980 (ISSN-L)
- 1521-4141
- OpenAlex
- W2025449580
- Cited by
- 775
- References
- 139
- FWCI
- 24.33
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.